Skip to content
van_bortel

Seminar Title

 

Seminar M2 – Risk analysis of the drug development process – focus on the patient

Affiliation

Heymans Institute of Pharmacology and Drug Research Unit Ghent (D.R.U.G.), Ghent University

Country

Belgium

1. Current Status, Position
 
Prof Dr Van Bortel is Professor clinical pharmacology and pharmacotherapy and Head of D.R.U.G., the University Hospital Unit for early phase clinical drug development.
 
2. Education
 
As medical doctor Luc Van Bortel specialized in internal medicine and clinical pharmacology. He obtained a PhD degree at Maastricht University where he was associate professor clinical pharmacology. From 2000 Luc Van Bortel is chairing the clinical pharmacology Unit at Ghent university. He is a certified trainer in clinical pharmacology.
 
3. Research Area
 
He has 28 years experience in early phase clinical drug development. Besides the early phase clinical drug development Luc Van Bortel’s research is situated in the cardiovascular domain, and in arterial research in particular. He is currently president of the ARTERY Society. 
 
Conflict of interest: None
×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.